Crossref journal-article
Springer Science and Business Media LLC
European Journal of Clinical Nutrition (297)
Bibliography

Laaksi, I. T., Ruohola, J.-P. S., Ylikomi, T. J., Auvinen, A., Haataja, R. I., Pihlajamäki, H. K., & Tuohimaa, P. J. (2006). Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men. European Journal of Clinical Nutrition, 60(8), 1035–1038.

Authors 7
  1. I T Laaksi (first)
  2. J-P S Ruohola (additional)
  3. T J Ylikomi (additional)
  4. A Auvinen (additional)
  5. R I Haataja (additional)
  6. H K Pihlajamäki (additional)
  7. P J Tuohimaa (additional)
References 23 Referenced 82
  1. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S et al. (1997). Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7, 439–443. (10.1007/s001980050030) / Osteoporos Int by MC Chapuy (1997)
  2. Compston JE (1998). Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ 317, 1466–1467. (10.1136/bmj.317.7171.1466) / BMJ by JE Compston (1998)
  3. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED (1989). Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2, 1176–1178. (10.1016/S0140-6736(89)91789-3) / Lancet by CF Garland (1989)
  4. Grant WB (2002). An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94, 272–281. (10.1002/cncr.10196) / Cancer by WB Grant (2002)
  5. Harkness L, Cromer B (2005). Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int 16, 109–113. (10.1007/s00198-004-1656-8) / Osteoporos Int by L Harkness (2005)
  6. Holick MF (2003a). Evolution and function of vitamin D. Recent Results Cancer Res 164, 3–28. (10.1007/978-3-642-55580-0_1) / Recent Results Cancer Res by MF Holick (2003)
  7. Holick MF (2003b). Vitamin D: a millenium perspective. J Cell Biochem 88, 296–307. (10.1002/jcb.10338) / J Cell Biochem by MF Holick (2003)
  8. Holick MF (2004). Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79, 362–371. (10.1093/ajcn/79.3.362) / Am J Clin Nutr by MF Holick (2004)
  9. Holick MF, Uskokovic M, Henley JW, MacLaughlin J, Holick SA, Potts Jr JT (1980). The photoproduction of 1 alpha,25-dihydroxyvitamin D3 in skin: an approach to the therapy of vitamin-D-resistant syndromes. N Engl J Med 303, 349–354. (10.1056/NEJM198008143030701) / N Engl J Med by MF Holick (1980)
  10. Jacques PF, Felson DT, Tucker KL, Mahnken B, Wilson PW, Rosenberg IH et al. (1997). Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr 66, 929–936. (10.1093/ajcn/66.4.929) / Am J Clin Nutr by PF Jacques (1997)
  11. Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B (1989). Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321, 1777–1783. (10.1056/NEJM198912283212602) / N Engl J Med by EA Krall (1989)
  12. Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ, Valsta LM (2001). Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 16, 2066–2073. (10.1359/jbmr.2001.16.11.2066) / J Bone Miner Res by CJ Lamberg-Allardt (2001)
  13. Lips P (2001). Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22, 477–501. (10.1210/edrv.22.4.0437) / Endocr Rev by P Lips (2001)
  14. Lou YR, Laaksi I, Syvala H, Blauer M, Tammela TL, Ylikomi T et al. (2004). 25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J 18, 332–334. (10.1096/fj.03-0140fje) / FASEB J by YR Lou (2004)
  15. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE (2000). 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87, 214–220. (10.1161/01.RES.87.3.214) / Circ Res by DJ Mantell (2000)
  16. McKenna MJ (1992). Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93, 69–77. (10.1016/0002-9343(92)90682-2) / Am J Med by MJ McKenna (1992)
  17. Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP (1997). 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 6, 727–732. / Cancer Epidemiol Biomarkers Prev by GG Schwartz (1997)
  18. Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF (2003). Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 77, 1478–1483. (10.1093/ajcn/77.6.1478) / Am J Clin Nutr by V Tangpricha (2003)
  19. Utiger RD (1998). The need for more vitamin D. N Engl J Med 338, 828–829. (10.1056/NEJM199803193381209) / N Engl J Med by RD Utiger (1998)
  20. Valimaki VV, Alfthan H, Lehmuskallio E, Loyttyniemi E, Sahi T, Stenman UH et al. (2004). Vitamin D status as a determinant of peak bone mass in young Finnish men. J Clin Endocrinol Metab 89, 76–80. (10.1210/jc.2003-030817) / J Clin Endocrinol Metab by VV Valimaki (2004)
  21. Webb AR, Kline L, Holick MF (1988). Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67, 373–378. (10.1210/jcem-67-2-373) / J Clin Endocrinol Metab by AR Webb (1988)
  22. Ylikomi T, Laaksi I, Lou YR, Martikainen P, Miettinen S, Pennanen P et al. (2002). Antiproliferative action of vitamin D. Vitam Horm 64, 357–406. (10.1016/S0083-6729(02)64010-5) / Vitam Horm by T Ylikomi (2002)
  23. Zittermann A (2003). Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89, 552–572. (10.1079/BJN2003837) / Br J Nutr by A Zittermann (2003)
Dates
Type When
Created 19 years, 6 months ago (Feb. 22, 2006, 6:54 a.m.)
Deposited 3 years, 5 months ago (March 24, 2022, 5:23 p.m.)
Indexed 4 months, 1 week ago (April 19, 2025, 4:48 a.m.)
Issued 19 years, 6 months ago (Feb. 15, 2006)
Published 19 years, 6 months ago (Feb. 15, 2006)
Published Online 19 years, 6 months ago (Feb. 15, 2006)
Published Print 19 years ago (Aug. 1, 2006)
Funders 0

None

@article{Laaksi_2006, title={Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men}, volume={60}, ISSN={1476-5640}, url={http://dx.doi.org/10.1038/sj.ejcn.1602414}, DOI={10.1038/sj.ejcn.1602414}, number={8}, journal={European Journal of Clinical Nutrition}, publisher={Springer Science and Business Media LLC}, author={Laaksi, I T and Ruohola, J-P S and Ylikomi, T J and Auvinen, A and Haataja, R I and Pihlajamäki, H K and Tuohimaa, P J}, year={2006}, month=feb, pages={1035–1038} }